@FiercePharma: Pfizer's Sutent falls flat in lung cancer. Article | Follow @FiercePharma
> In a victory for Sanofi-Aventis, the U.K. cost watchdog NICE has given a restricted approval to Multaq as a second line treatment for atrial fibrillation patients. Report
> British drugmaker Shire could face competition from a generic version of its gastrointestinal drug Pentasa after a ruling from U.S. regulators. Story
> Ovarian cancer test shows near 100 percent accuracy. Article
> Britain's cost watchdog won't recommend Novartis' key oncology drug Gleevec as a follow-up treatment for stomach cancer patients, due to cost/benefit considerations. Item
> Stirling Pharma's new Canadian plant will open its doors in late September, and first to come off the production line will be the drug acetaminophen. News
> Medco probes usefulness of markers for antipsychotics. Report
> Federal health officials are gearing up to persuade more Americans to get vaccinated against the flu this fall in the aftermath of last year's pandemic. Article
> Renin emerges as a definitive marker for hypertension drugs. Story
> A review of U.S. capabilities has concluded that the time to produce a pandemic vaccine could be halved through adoption of short-term policies. Report
Biotech News
@FierceBiotech: Eisai reports upbeat results from PhIII epilepsy study. Article | Follow @FierceBiotech
@JohnCFierce:If a sitting president can't trump a federal judge on embryonic stem cell policy, I'll be very surprised. | Follow @JohnCFierce
> Notch inhibitors may offer breakthrough on brain cancer. Article
> Stem cell researchers slammed with funding freeze. Report
> Dahlen tapped as NeuroSearch CEO. Story
Drug Delivery News
> Tel Aviv researchers create new weapon against cancer. News
> Vyteris, Georgia Tech to develop transdermal drug delivery. Report
> E-cigarette battle lines form in federal court. Item
> Roche staples together Aileron deal worth up to $1.1 billion. News
> The eyes have it for non-viral gene therapy. Story
> Celsion's ThermoDox liver cancer trials get fast-tracked. Article
Medical Device News
@FierceMedDev: Researchers have found no benefit to gender-specific knee transplants. Article | Follow @FierceMedDev
> Medtronic hit hard on Q1 results. Item
> J&J unit warned on hip and knee replacement systems. Item
> NeuroVista raises $21.5 million for epilepsy device. Story
> Roche purchases BioImagene for approx. $100 million. Article
> Boston Sci fetes Minn employees. Report
> J&J unit recalls contact lenses in certain Asian, European markets. Story
And Finally... Adding an experimental drug to chemotherapy helped wipe out brain cancer cells in mice, offering a promising new treatment approach for the deadly cancer. Report